PDSB
Price
$1.08
Change
+$0.02 (+1.87%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
49.6M
12 days until earnings call
STRO
Price
$0.81
Change
-$0.00 (-0.00%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
68.47M
6 days until earnings call
Interact to see
Advertisement

PDSB vs STRO

Header iconPDSB vs STRO Comparison
Open Charts PDSB vs STROBanner chart's image
PDS Biotechnology
Price$1.08
Change+$0.02 (+1.87%)
Volume$1.2K
Capitalization49.6M
Sutro Biopharma
Price$0.81
Change-$0.00 (-0.00%)
Volume$8.92K
Capitalization68.47M
PDSB vs STRO Comparison Chart in %
Loading...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PDSB vs. STRO commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDSB is a Hold and STRO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (PDSB: $1.06 vs. STRO: $0.81)
Brand notoriety: PDSB and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PDSB: 42% vs. STRO: 30%
Market capitalization -- PDSB: $48.45M vs. STRO: $68.02M
PDSB [@Biotechnology] is valued at $48.45M. STRO’s [@Biotechnology] market capitalization is $68.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $223.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDSB’s FA Score shows that 1 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • PDSB’s FA Score: 1 green, 4 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, STRO is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDSB’s TA Score shows that 4 TA indicator(s) are bullish while STRO’s TA Score has 5 bullish TA indicator(s).

  • PDSB’s TA Score: 4 bullish, 4 bearish.
  • STRO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both PDSB and STRO are a good buy in the short-term.

Price Growth

PDSB (@Biotechnology) experienced а -12.40% price change this week, while STRO (@Biotechnology) price change was -11.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

Reported Earning Dates

PDSB is expected to report earnings on Nov 12, 2025.

STRO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STRO($68.5M) has a higher market cap than PDSB($49.6M). PDSB YTD gains are higher at: -34.969 vs. STRO (-56.234). PDSB has higher annual earnings (EBITDA): -33.08M vs. STRO (-203.18M). STRO has more cash in the bank: 249M vs. PDSB (40M). PDSB has less debt than STRO: PDSB (19M) vs STRO (21.4M). STRO has higher revenues than PDSB: STRO (66.4M) vs PDSB (0).
PDSBSTROPDSB / STRO
Capitalization49.6M68.5M72%
EBITDA-33.08M-203.18M16%
Gain YTD-34.969-56.23462%
P/E RatioN/AN/A-
Revenue066.4M-
Total Cash40M249M16%
Total Debt19M21.4M89%
FUNDAMENTALS RATINGS
PDSB vs STRO: Fundamental Ratings
PDSB
STRO
OUTLOOK RATING
1..100
5313
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9164
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STRO's Valuation (26) in the Pharmaceuticals Major industry is in the same range as PDSB (28). This means that STRO’s stock grew similarly to PDSB’s over the last 12 months.

STRO's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as PDSB (100). This means that STRO’s stock grew similarly to PDSB’s over the last 12 months.

PDSB's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as STRO (100). This means that PDSB’s stock grew similarly to STRO’s over the last 12 months.

STRO's Price Growth Rating (64) in the Pharmaceuticals Major industry is in the same range as PDSB (91). This means that STRO’s stock grew similarly to PDSB’s over the last 12 months.

STRO's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as PDSB (100). This means that STRO’s stock grew similarly to PDSB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PDSBSTRO
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 24 days ago
86%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JBTC25.000.25
+1.01%
JBT Bancorp Inc.
PPAAF0.10N/A
N/A
PT Perusahaan Gas Negara Persaro
BGOPF1.18N/A
N/A
Bango plc
GBCS2.15N/A
N/A
Selectis Health,Inc.
PMMAF21.39-1.77
-7.64%
Puma AG Rudolf Dassler Sport

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with ARCT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
-3.64%
ARCT - PDSB
50%
Loosely correlated
-3.59%
RXRX - PDSB
47%
Loosely correlated
-0.17%
IDYA - PDSB
45%
Loosely correlated
-3.94%
DYN - PDSB
44%
Loosely correlated
-0.61%
NRIX - PDSB
44%
Loosely correlated
-5.22%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with ALGS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then ALGS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
-8.44%
ALGS - STRO
44%
Loosely correlated
-6.75%
BEAM - STRO
39%
Loosely correlated
-2.23%
PDSB - STRO
39%
Loosely correlated
-3.64%
FATE - STRO
38%
Loosely correlated
-3.07%
TCRX - STRO
38%
Loosely correlated
-4.42%
More